首页> 外文期刊>Endocrinology and Metabolism Clinics of North America >Type 2 diabetes mellitus and hypertension: An update
【24h】

Type 2 diabetes mellitus and hypertension: An update

机译:2型糖尿病和高血压:最新动态

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with hypertension and type 2 diabetes are at increased risk of cardiovascular and chronic renal disease. Factors involved in the pathogenesis of both hypertension and type 2 diabetes include inappropriate activation of the renin-angiotensin-aldosterone system, oxidative stress, inflammation, impaired insulin-mediated vasodilatation, augmented sympathetic nervous system activation, altered innate and adaptive immunity, and abnormal sodium processing by the kidney. The renin-angiotensin-aldosterone system blockade is a key therapeutic strategy in the treatment of hypertension in type 2 diabetes. Emerging therapies for resistant hypertension as often exists in patients with diabetes, include renal denervation and carotid body denervation.
机译:患有高血压和2型糖尿病的患者罹患心血管疾病和慢性肾脏疾病的风险增加。与高血压和2型糖尿病的发病机制有关的因素包括肾素-血管紧张素-醛固酮系统的不适当活化,氧化应激,炎症,胰岛素介导的血管舒张受损,交感神经系统活化增强,先天和适应性免疫力改变以及钠异常由肾脏加工。肾素-血管紧张素-醛固酮系统阻滞是治疗2型糖尿病高血压的关键治疗策略。糖尿病患者中经常出现的针对抗药性高血压的新疗法包括肾神经支配和颈动脉体神经支配。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号